/Companies

Sentynl

1 known investors

Find your way into Sentynl

53 people in our graph share verified history with the Sentynl team — schools, employers, funds. One of them is your warm intro.

Chris Murphyunlockedknows Matt Heck · together at Darla Moore School of Business at the University of South Carolina (overlapped)
×11knows the team · via Darla Moore School of Business at the University of South Carolina

A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.

Founders & leadership

MHMatt Heck
Matt HeckFounder & CEOHe previously co-founded Victory Pharmaceuticals where he served as CEO, was VP of Sales at DJ Pharma (which was acquired by Biovail), and held commercial roles at Dura Pharmaceuticals and Dial Corporation; he holds a Bachelor of Arts in marketing from the University of South Carolina.

Investors · 1

Frequently asked questions

What does Sentynl do?
A biopharmaceutical company developing novel medicines for rare diseases, serving patients and caregivers from early detection through therapeutic intervention.
Who founded Sentynl?
Sentynl was founded by Matt Heck.
Who are Sentynl's investors?
Sentynl's investors include Avego BioScience Capital.